🎥 Have you read our latest article?

We recently published our latest scientific publication in the International Journal of Molecular Sciences MDPI :

📖 "Optimizing #CTC Detection in #BreastCancer: Unveiling Novel Markers for Clinical Applications"

🗓️ Published on May 14, 2025

📢 Our Chief Scientific Officer, Dr. Georges Uzan, will represent #ScreenCell at the #ELBS 2025 Annual General Meeting in Madrid, Spain 🇪🇸 on Nov 3–4, 2025.

He’ll be on site to exchange with members of the #LiquidBiopsy community and discuss future collaborations.

#CTC

Thanks to @bpifrance-officiel.bsky.social and Mathilde Nourian-Tixier-Perenet for this wonderful showcase of our liquid biopsy technology during #OctobreRose 💗

A fascinating article on the future of cancer and CTC monitoring 👇
bigmedia.bpifrance.fr/nos-actualit...

🎥 Q&A: Emile Lakis, PhD answers your question! #1 👩‍🔬
You ask us your questions, we answer them 🎯

Today, our Technical Sales Manager answers a frequently asked question:
"Are ScreenCell kits for #circulatingtumorcell #CTC isolation only RUO?"

A question in mind? Leave it in the comments 💭

🎀 #PinkOctober 💗

At ScreenCell®, the fight against cancer is at the heart of our mission.

For Pink October, we're turning all our social media channels pink to show our support for research, patients, caregivers, and all those affected by breast cancer.

#octobrerose2025

📸 Thank you #ACTC2025!

🙏 Thank you to everyone who came to chat with us at our booth, participate in our live demonstrations, and attend the oral presentation by our Technical Director, Dr. Sina NASERIAN.

We look forward to seeing you at the 8th edition of ACTC!

📢 #ACTC2025 continues until tomorrow!

✨ Don't miss our oral presentation today, from 3:00 PM to 3:20 PM, where we will demonstrate our #CTCisolationtechnology and share our latest clinical data on the uses of circulating tumor cells #CTCs in a routine clinical setting.

🎉 #ACTC2025 kicks off today on #WorldCancerResearchDay !

📍 Find us at booth #1 to discover our CTC isolation technology, exchange with our team, and even take part in live demonstrations.

Our CTO, Dr. Sina NASERIAN, will be speaking at an oral presentation at the #ACTC2025!

📍 ScreenCell® Technology: Tailored and Cost-Effective CTC Analysis Platform Meeting Clinical Oncology Needs
🗓️ September 26th
⏰ 15:00 to 15:20

Visit us at stand #1

What if you could isolate #circulatingtumorcells (#CTCs) faster than reading a scientific publication? 📖

With our single-use isolation devices, isolate your CTCs using #liquidbiopsy in less than 10 minutes, with a recovery rate greater than 90%. ⚡

ScreenCell at ACTC 2025 – Booth #1 ✨

We are proud to announce our participation as an exhibitor at the 7th ACTC, which will be held in Thessaloniki, Greece, from September 24-27, 2025, organized by Evi Lianidou and Hellenic Society of Liquid Biopsy.

🎗 World Lung Cancer Day

Lung cancer is the most common cancer worldwide, with 2.5M new cases/year.

It can strike anyone, anytime, silently.

🔬 Discover our #CTC research & that of our partners:

www.screencell.com/en/scientifi...

🩸"Health is priceless!" 💵
Do you agree with this statement?

“If health is priceless, it still comes at a cost.” And we’re fully aware of that.

🎥 Are you working on circulating tumor cells (#CTCs) and looking to accurately detect mutations? Don't miss the replay of our webinar in collaboration with @stillatechnologies.bsky.social ! 🔬

📩 The replay is now available on-demand: www.screencell.com/en/webinar-s...

#Liquidbiopsy #Oncology

🔬 Discover every detail of our isolation platform for capturing #circulatingtumorcells using #liquidbiopsy 🩸

Would you like to know how to integrate our technology into your #research project?

Contact us : lnkd.in/edURqtjQ

🩸 Can surgery promote the spread of circulating tumor cells (CTCs)?

In non-small cell lung cancer (NSCLC), researchers using our technology detected more CTCs after surgery, which is associated with a higher risk of recurrence five years later.

🔬 New publication! ScreenCell® technology enhances Circulating Tumor Cell detection in breast cancer using new biomarkers 🧬

📖 Published May 14, 2025
📎 www.mdpi.com/1422-0067/26...

Led by Sina NASERIAN and Amira Mehtar, in collaboration with Inserm and Kahia/Genethical Lab in Algeria.